0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Gut Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-7U17347
Home | Market Reports | Science| Biological Sciences
Global Human Gut Chip Market Research Report 2024
BUY CHAPTERS

Global Human Gut Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7U17347
Report
November 2025
Pages:174
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Gut Chip Market Size

The global Human Gut Chip market is projected to grow from US$ 872 million in 2024 to US$ 2799 million by 2031, at a CAGR of 18.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Human Gut Chip Market

Human Gut Chip Market

Human Gut Chip is a biosimulation technology designed to simulate the structure and function of the human intestine, usually implemented on a microfluidic chip or microbial chip. This technology uses tissue engineering and biotechnology to plant artificially cultured intestinal cells on a chip to simulate various characteristics of the real intestine, such as mucosal layer, intestinal peristalsis, intestinal flora, etc. Human gut chips can be used to simulate the digestive process, absorb and transport substances, study the pathogenesis of intestinal diseases, and evaluate the absorption, toxicity and efficacy of drugs. This technology provides a highly controllable and reproducible experimental platform for intestinal-related research, helps understand intestinal physiology and pathology, and accelerates the development and evaluation of new drugs.
As an important branch of the biomedical field, the human intestinal chip market has shown rapid development and active innovation in recent years. With the continuous breakthroughs in biotechnology and the growing demand for personalized medicine, the human intestinal chip market is experiencing rapid expansion. More and more research institutions and companies are beginning to get involved in this field, driving the market scale to continue to expand. In short, the human intestinal chip market is in a rapid development stage, with broad application prospects and huge market potential.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Gut Chip market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Human Gut Chip Market Report

Report Metric Details
Report Name Human Gut Chip Market
Accounted market size in 2024 US$ 872 million
Forecasted market size in 2031 US$ 2799 million
CAGR 18.4%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Static Chip
  • Dynamic Chip
Segment by Application
  • Medical Diagnosis
  • New Medical Research
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emulate, TissUse, HμREL, CN Bio Innovations, Mimetas, Hurel, AxoSim, Nortis, Mucosal Immunology and Biology Research Center, SynVivo, Tara Biosystems, Kugelmeiers, Ascendance Biotechnology, ChipScreen Biosciences, BGI Genomics, Zhejiang Ruiao Biotechnology, WuXi AppTec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Human Gut Chip study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Human Gut Chip Market growing?

Ans: The Human Gut Chip Market witnessing a CAGR of 18.4% during the forecast period 2025-2031.

What is the Human Gut Chip Market size in 2031?

Ans: The Human Gut Chip Market size in 2031 will be US$ 2799 million.

Who are the main players in the Human Gut Chip Market report?

Ans: The main players in the Human Gut Chip Market are Emulate, TissUse, HμREL, CN Bio Innovations, Mimetas, Hurel, AxoSim, Nortis, Mucosal Immunology and Biology Research Center, SynVivo, Tara Biosystems, Kugelmeiers, Ascendance Biotechnology, ChipScreen Biosciences, BGI Genomics, Zhejiang Ruiao Biotechnology, WuXi AppTec

What are the Application segmentation covered in the Human Gut Chip Market report?

Ans: The Applications covered in the Human Gut Chip Market report are Medical Diagnosis, New Medical Research, Other

What are the Type segmentation covered in the Human Gut Chip Market report?

Ans: The Types covered in the Human Gut Chip Market report are Static Chip, Dynamic Chip

1 Study Coverage
1.1 Introduction to Human Gut Chip: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Gut Chip Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Static Chip
1.2.3 Dynamic Chip
1.3 Market Segmentation by Application
1.3.1 Global Human Gut Chip Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Diagnosis
1.3.3 New Medical Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Gut Chip Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Gut Chip Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Human Gut Chip Sales Estimates and Forecasts 2020-2031
2.4 Global Human Gut Chip Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Human Gut Chip Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Human Gut Chip Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Static Chip Market Size by Manufacturers
3.5.2 Dynamic Chip Market Size by Manufacturers
3.6 Global Human Gut Chip Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Gut Chip Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Human Gut Chip Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Gut Chip Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Human Gut Chip Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Human Gut Chip Sales and Revenue by Type (2020-2031)
6.4 North America Human Gut Chip Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Gut Chip Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Human Gut Chip Sales and Revenue by Type (2020-2031)
7.4 Europe Human Gut Chip Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Gut Chip Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Human Gut Chip Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Human Gut Chip Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Human Gut Chip Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Human Gut Chip Sales and Revenue by Type (2020-2031)
9.4 Central and South America Human Gut Chip Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Gut Chip Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Human Gut Chip Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Human Gut Chip Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Gut Chip Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Emulate
11.1.1 Emulate Corporation Information
11.1.2 Emulate Business Overview
11.1.3 Emulate Human Gut Chip Product Models, Descriptions and Specifications
11.1.4 Emulate Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Emulate Human Gut Chip Sales by Product in 2024
11.1.6 Emulate Human Gut Chip Sales by Application in 2024
11.1.7 Emulate Human Gut Chip Sales by Geographic Area in 2024
11.1.8 Emulate Human Gut Chip SWOT Analysis
11.1.9 Emulate Recent Developments
11.2 TissUse
11.2.1 TissUse Corporation Information
11.2.2 TissUse Business Overview
11.2.3 TissUse Human Gut Chip Product Models, Descriptions and Specifications
11.2.4 TissUse Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 TissUse Human Gut Chip Sales by Product in 2024
11.2.6 TissUse Human Gut Chip Sales by Application in 2024
11.2.7 TissUse Human Gut Chip Sales by Geographic Area in 2024
11.2.8 TissUse Human Gut Chip SWOT Analysis
11.2.9 TissUse Recent Developments
11.3 HμREL
11.3.1 HμREL Corporation Information
11.3.2 HμREL Business Overview
11.3.3 HμREL Human Gut Chip Product Models, Descriptions and Specifications
11.3.4 HμREL Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 HμREL Human Gut Chip Sales by Product in 2024
11.3.6 HμREL Human Gut Chip Sales by Application in 2024
11.3.7 HμREL Human Gut Chip Sales by Geographic Area in 2024
11.3.8 HμREL Human Gut Chip SWOT Analysis
11.3.9 HμREL Recent Developments
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Corporation Information
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Human Gut Chip Product Models, Descriptions and Specifications
11.4.4 CN Bio Innovations Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CN Bio Innovations Human Gut Chip Sales by Product in 2024
11.4.6 CN Bio Innovations Human Gut Chip Sales by Application in 2024
11.4.7 CN Bio Innovations Human Gut Chip Sales by Geographic Area in 2024
11.4.8 CN Bio Innovations Human Gut Chip SWOT Analysis
11.4.9 CN Bio Innovations Recent Developments
11.5 Mimetas
11.5.1 Mimetas Corporation Information
11.5.2 Mimetas Business Overview
11.5.3 Mimetas Human Gut Chip Product Models, Descriptions and Specifications
11.5.4 Mimetas Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Mimetas Human Gut Chip Sales by Product in 2024
11.5.6 Mimetas Human Gut Chip Sales by Application in 2024
11.5.7 Mimetas Human Gut Chip Sales by Geographic Area in 2024
11.5.8 Mimetas Human Gut Chip SWOT Analysis
11.5.9 Mimetas Recent Developments
11.6 Hurel
11.6.1 Hurel Corporation Information
11.6.2 Hurel Business Overview
11.6.3 Hurel Human Gut Chip Product Models, Descriptions and Specifications
11.6.4 Hurel Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hurel Recent Developments
11.7 AxoSim
11.7.1 AxoSim Corporation Information
11.7.2 AxoSim Business Overview
11.7.3 AxoSim Human Gut Chip Product Models, Descriptions and Specifications
11.7.4 AxoSim Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AxoSim Recent Developments
11.8 Nortis
11.8.1 Nortis Corporation Information
11.8.2 Nortis Business Overview
11.8.3 Nortis Human Gut Chip Product Models, Descriptions and Specifications
11.8.4 Nortis Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Nortis Recent Developments
11.9 Mucosal Immunology and Biology Research Center
11.9.1 Mucosal Immunology and Biology Research Center Corporation Information
11.9.2 Mucosal Immunology and Biology Research Center Business Overview
11.9.3 Mucosal Immunology and Biology Research Center Human Gut Chip Product Models, Descriptions and Specifications
11.9.4 Mucosal Immunology and Biology Research Center Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Mucosal Immunology and Biology Research Center Recent Developments
11.10 SynVivo
11.10.1 SynVivo Corporation Information
11.10.2 SynVivo Business Overview
11.10.3 SynVivo Human Gut Chip Product Models, Descriptions and Specifications
11.10.4 SynVivo Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 SynVivo Recent Developments
11.11 Tara Biosystems
11.11.1 Tara Biosystems Corporation Information
11.11.2 Tara Biosystems Business Overview
11.11.3 Tara Biosystems Human Gut Chip Product Models, Descriptions and Specifications
11.11.4 Tara Biosystems Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tara Biosystems Recent Developments
11.12 Kugelmeiers
11.12.1 Kugelmeiers Corporation Information
11.12.2 Kugelmeiers Business Overview
11.12.3 Kugelmeiers Human Gut Chip Product Models, Descriptions and Specifications
11.12.4 Kugelmeiers Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Kugelmeiers Recent Developments
11.13 Ascendance Biotechnology
11.13.1 Ascendance Biotechnology Corporation Information
11.13.2 Ascendance Biotechnology Business Overview
11.13.3 Ascendance Biotechnology Human Gut Chip Product Models, Descriptions and Specifications
11.13.4 Ascendance Biotechnology Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Ascendance Biotechnology Recent Developments
11.14 ChipScreen Biosciences
11.14.1 ChipScreen Biosciences Corporation Information
11.14.2 ChipScreen Biosciences Business Overview
11.14.3 ChipScreen Biosciences Human Gut Chip Product Models, Descriptions and Specifications
11.14.4 ChipScreen Biosciences Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 ChipScreen Biosciences Recent Developments
11.15 BGI Genomics
11.15.1 BGI Genomics Corporation Information
11.15.2 BGI Genomics Business Overview
11.15.3 BGI Genomics Human Gut Chip Product Models, Descriptions and Specifications
11.15.4 BGI Genomics Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 BGI Genomics Recent Developments
11.16 Zhejiang Ruiao Biotechnology
11.16.1 Zhejiang Ruiao Biotechnology Corporation Information
11.16.2 Zhejiang Ruiao Biotechnology Business Overview
11.16.3 Zhejiang Ruiao Biotechnology Human Gut Chip Product Models, Descriptions and Specifications
11.16.4 Zhejiang Ruiao Biotechnology Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Zhejiang Ruiao Biotechnology Recent Developments
11.17 WuXi AppTec
11.17.1 WuXi AppTec Corporation Information
11.17.2 WuXi AppTec Business Overview
11.17.3 WuXi AppTec Human Gut Chip Product Models, Descriptions and Specifications
11.17.4 WuXi AppTec Human Gut Chip Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 WuXi AppTec Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Human Gut Chip Industry Chain
12.2 Human Gut Chip Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Human Gut Chip Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Human Gut Chip Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Gut Chip Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Gut Chip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Human Gut Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Human Gut Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Human Gut Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Human Gut Chip Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Human Gut Chip Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Human Gut Chip Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Human Gut Chip Sales by Region (2020-2025) & (K Units)
 Table 8. Global Human Gut Chip Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Human Gut Chip Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Human Gut Chip Sales Share by Manufacturers (2020-2025)
 Table 12. Global Human Gut Chip Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Human Gut Chip Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Human Gut Chip by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gut Chip as of 2024)
 Table 16. Global Human Gut Chip Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Human Gut Chip Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Human Gut Chip Manufacturing Base and Headquarters
 Table 19. Global Human Gut Chip Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Human Gut Chip Sales by Type (2020-2025) & (K Units)
 Table 23. Global Human Gut Chip Sales by Type (2026-2031) & (K Units)
 Table 24. Global Human Gut Chip Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Human Gut Chip Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Human Gut Chip ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Human Gut Chip Sales by Application (2020-2025) & (K Units)
 Table 29. Global Human Gut Chip Sales by Application (2026-2031) & (K Units)
 Table 30. Human Gut Chip High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Human Gut Chip Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Human Gut Chip Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Human Gut Chip ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Human Gut Chip Growth Accelerators and Market Barriers
 Table 37. North America Human Gut Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Human Gut Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Human Gut Chip Growth Accelerators and Market Barriers
 Table 40. Europe Human Gut Chip Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Human Gut Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Human Gut Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Human Gut Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Human Gut Chip Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Human Gut Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Human Gut Chip Investment Opportunities and Key Challenges
 Table 47. Central and South America Human Gut Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Human Gut Chip Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Human Gut Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Emulate Corporation Information
 Table 51. Emulate Description and Major Businesses
 Table 52. Emulate Product Models, Descriptions and Specifications
 Table 53. Emulate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Emulate Sales Value Proportion by Product in 2024
 Table 55. Emulate Sales Value Proportion by Application in 2024
 Table 56. Emulate Sales Value Proportion by Geographic Area in 2024
 Table 57. Emulate Human Gut Chip SWOT Analysis
 Table 58. Emulate Recent Developments
 Table 59. TissUse Corporation Information
 Table 60. TissUse Description and Major Businesses
 Table 61. TissUse Product Models, Descriptions and Specifications
 Table 62. TissUse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. TissUse Sales Value Proportion by Product in 2024
 Table 64. TissUse Sales Value Proportion by Application in 2024
 Table 65. TissUse Sales Value Proportion by Geographic Area in 2024
 Table 66. TissUse Human Gut Chip SWOT Analysis
 Table 67. TissUse Recent Developments
 Table 68. HμREL Corporation Information
 Table 69. HμREL Description and Major Businesses
 Table 70. HμREL Product Models, Descriptions and Specifications
 Table 71. HμREL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. HμREL Sales Value Proportion by Product in 2024
 Table 73. HμREL Sales Value Proportion by Application in 2024
 Table 74. HμREL Sales Value Proportion by Geographic Area in 2024
 Table 75. HμREL Human Gut Chip SWOT Analysis
 Table 76. HμREL Recent Developments
 Table 77. CN Bio Innovations Corporation Information
 Table 78. CN Bio Innovations Description and Major Businesses
 Table 79. CN Bio Innovations Product Models, Descriptions and Specifications
 Table 80. CN Bio Innovations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. CN Bio Innovations Sales Value Proportion by Product in 2024
 Table 82. CN Bio Innovations Sales Value Proportion by Application in 2024
 Table 83. CN Bio Innovations Sales Value Proportion by Geographic Area in 2024
 Table 84. CN Bio Innovations Human Gut Chip SWOT Analysis
 Table 85. CN Bio Innovations Recent Developments
 Table 86. Mimetas Corporation Information
 Table 87. Mimetas Description and Major Businesses
 Table 88. Mimetas Product Models, Descriptions and Specifications
 Table 89. Mimetas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Mimetas Sales Value Proportion by Product in 2024
 Table 91. Mimetas Sales Value Proportion by Application in 2024
 Table 92. Mimetas Sales Value Proportion by Geographic Area in 2024
 Table 93. Mimetas Human Gut Chip SWOT Analysis
 Table 94. Mimetas Recent Developments
 Table 95. Hurel Corporation Information
 Table 96. Hurel Description and Major Businesses
 Table 97. Hurel Product Models, Descriptions and Specifications
 Table 98. Hurel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Hurel Recent Developments
 Table 100. AxoSim Corporation Information
 Table 101. AxoSim Description and Major Businesses
 Table 102. AxoSim Product Models, Descriptions and Specifications
 Table 103. AxoSim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. AxoSim Recent Developments
 Table 105. Nortis Corporation Information
 Table 106. Nortis Description and Major Businesses
 Table 107. Nortis Product Models, Descriptions and Specifications
 Table 108. Nortis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Nortis Recent Developments
 Table 110. Mucosal Immunology and Biology Research Center Corporation Information
 Table 111. Mucosal Immunology and Biology Research Center Description and Major Businesses
 Table 112. Mucosal Immunology and Biology Research Center Product Models, Descriptions and Specifications
 Table 113. Mucosal Immunology and Biology Research Center Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Mucosal Immunology and Biology Research Center Recent Developments
 Table 115. SynVivo Corporation Information
 Table 116. SynVivo Description and Major Businesses
 Table 117. SynVivo Product Models, Descriptions and Specifications
 Table 118. SynVivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. SynVivo Recent Developments
 Table 120. Tara Biosystems Corporation Information
 Table 121. Tara Biosystems Description and Major Businesses
 Table 122. Tara Biosystems Product Models, Descriptions and Specifications
 Table 123. Tara Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Tara Biosystems Recent Developments
 Table 125. Kugelmeiers Corporation Information
 Table 126. Kugelmeiers Description and Major Businesses
 Table 127. Kugelmeiers Product Models, Descriptions and Specifications
 Table 128. Kugelmeiers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Kugelmeiers Recent Developments
 Table 130. Ascendance Biotechnology Corporation Information
 Table 131. Ascendance Biotechnology Description and Major Businesses
 Table 132. Ascendance Biotechnology Product Models, Descriptions and Specifications
 Table 133. Ascendance Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Ascendance Biotechnology Recent Developments
 Table 135. ChipScreen Biosciences Corporation Information
 Table 136. ChipScreen Biosciences Description and Major Businesses
 Table 137. ChipScreen Biosciences Product Models, Descriptions and Specifications
 Table 138. ChipScreen Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. ChipScreen Biosciences Recent Developments
 Table 140. BGI Genomics Corporation Information
 Table 141. BGI Genomics Description and Major Businesses
 Table 142. BGI Genomics Product Models, Descriptions and Specifications
 Table 143. BGI Genomics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. BGI Genomics Recent Developments
 Table 145. Zhejiang Ruiao Biotechnology Corporation Information
 Table 146. Zhejiang Ruiao Biotechnology Description and Major Businesses
 Table 147. Zhejiang Ruiao Biotechnology Product Models, Descriptions and Specifications
 Table 148. Zhejiang Ruiao Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Zhejiang Ruiao Biotechnology Recent Developments
 Table 150. WuXi AppTec Corporation Information
 Table 151. WuXi AppTec Description and Major Businesses
 Table 152. WuXi AppTec Product Models, Descriptions and Specifications
 Table 153. WuXi AppTec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. WuXi AppTec Recent Developments
 Table 155. Key Raw Materials Distribution
 Table 156. Raw Materials Key Suppliers
 Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 158. Milestones in Production Technology Evolution
 Table 159. Distributors List
 Table 160. Market Trends and Market Evolution
 Table 161. Market Drivers and Opportunities
 Table 162. Market Challenges, Risks, and Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Gut Chip Product Picture
 Figure 2. Global Human Gut Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Static Chip Product Picture
 Figure 4. Dynamic Chip Product Picture
 Figure 5. Global Human Gut Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Medical Diagnosis
 Figure 7. New Medical Research
 Figure 8. Other
 Figure 9. Human Gut Chip Report Years Considered
 Figure 10. Global Human Gut Chip Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Human Gut Chip Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Human Gut Chip Revenue Market Share by Region (2020-2031)
 Figure 14. Global Human Gut Chip Sales (2020-2031) & (K Units)
 Figure 15. Global Human Gut Chip Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Human Gut Chip Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Human Gut Chip Sales Volume Market Share in 2024
 Figure 18. Global Human Gut Chip Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Static Chip Revenue Market Share by Manufacturer in 2024
 Figure 21. Dynamic Chip Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Human Gut Chip Sales Market Share by Type (2020-2031)
 Figure 23. Global Human Gut Chip Revenue Market Share by Type (2020-2031)
 Figure 24. Global Human Gut Chip Sales Market Share by Application (2020-2031)
 Figure 25. Global Human Gut Chip Revenue Market Share by Application (2020-2031)
 Figure 26. North America Human Gut Chip Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Human Gut Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Human Gut Chip Sales Revenue (US$ Million) in 2024
 Figure 29. North America Human Gut Chip Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Human Gut Chip Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Human Gut Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Human Gut Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Human Gut Chip Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Human Gut Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Human Gut Chip Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Human Gut Chip Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Human Gut Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Human Gut Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Human Gut Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 44. France Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Human Gut Chip Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Human Gut Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Human Gut Chip Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Human Gut Chip Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Human Gut Chip Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Human Gut Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Human Gut Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 59. India Human Gut Chip Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Human Gut Chip Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Human Gut Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Human Gut Chip Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Human Gut Chip Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Human Gut Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Human Gut Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Human Gut Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Human Gut Chip Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Human Gut Chip Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Human Gut Chip Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Human Gut Chip Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Human Gut Chip Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Human Gut Chip Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Human Gut Chip Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Human Gut Chip Revenue (2020-2025) & (US$ Million)
 Figure 80. Human Gut Chip Industry Chain Mapping
 Figure 81. Regional Human Gut Chip Manufacturing Base Distribution (%)
 Figure 82. Global Human Gut Chip Production Market Share by Region (2020-2031)
 Figure 83. Human Gut Chip Production Process
 Figure 84. Regional Human Gut Chip Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI